|
Volumn 18, Issue 2, 1990, Pages 321-324
|
Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarrazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report
a a b a a a a |
Author keywords
BCNU; CCNU; Chemotherapy; Glioblastoma multiforme; Glioma; PCV; Procarbazine
|
Indexed keywords
CARMUSTINE;
HYDROXYUREA;
LOMUSTINE;
PROCARBAZINE;
VINCRISTINE;
ADULT;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
FEMALE;
GLIOBLASTOMA;
GLIOMA;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
METHODOLOGY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RADIOTHERAPY;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BRAIN NEOPLASMS;
CARMUSTINE;
COMBINED MODALITY THERAPY;
COMPARATIVE STUDY;
GLIOBLASTOMA;
GLIOMA;
HUMAN;
LOMUSTINE;
MIDDLE AGE;
MULTICENTER STUDIES;
PROCARBAZINE;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
SUPPORT, U.S. GOV'T, P.H.S.;
UNITED STATES;
VINCRISTINE;
|
EID: 0025239917
PISSN: 03603016
EISSN: None
Source Type: Journal
DOI: 10.1016/0360-3016(90)90096-3 Document Type: Article |
Times cited : (372)
|
References (15)
|